In addition, aCLL patients demonstrated a higher expression of CD23, but no significant difference was noted between aCLL and classic CLL regarding the expression of surface immunoglobulin (sIg), CD79b, or CD5. This evidence concerns the gene CD5 and B-cell chronic lymphocytic leukemia.